ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CLA1360 |
|
1442657-12-6 |
Pasotuxizumab 95+% |
— | |
CLA1356 |
|
1630074-14-4 |
Denintuzumab (Anti-CD19) 95+% |
— | |
CLA1354 |
|
946415-62-9 |
Ontuxizumab (Anti-TEM1 / Endosialin / CD248) 95+% |
— | |
CLA1353 |
|
1269764-99-9 |
Coltuximab (Anti-CD19) 95+% |
— | |
CLA1345 |
|
1416147-64-2 |
Dapirolizumab pegol 95+% |
— | |
CLA1324 |
|
1313706-14-7 |
Pinatuzumab (Anti-Siglec-2 / CD22) 95+% |
— | |
CLA1308 |
|
1169956-08-4 |
Ocaratuzumab (Anti-CD20) 95+% |
— | |
CLA1293 |
|
1005198-65-1 |
Solitomab 95+% |
— | |
CLA1287 |
|
1238217-55-4 |
Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) 95+% |
— | |
CLA1282 |
|
1188275-92-4 |
Narnatumab (Anti-MSPR / RON / CD136) 95+% |
— | |
CLA1275 |
|
934823-49-1 |
Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) 95+% |
— | |
CLA1274 |
|
1174014-05-1 |
Ublituximab (Anti-CD20) 95+% |
— | |
CLA1273 |
|
1207446-68-1 |
Tregalizumab (Anti-CD4) 95+% |
— | |
CLA1260 |
|
1073059-33-2 |
Samalizumab (Anti-CD200) 95+% |
— | |
CLA1259 |
|
1174008-79-7 |
Roledumab (Anti-RHD / CD240d) 95+% |
— | |
CLA1258 |
|
1186098-83-8 |
Oxelumab (Anti-TNFSF4 / OX40L / CD252) 95+% |
— | |
CLA1255 |
|
1116433-11-4 |
Itolizumab (Anti-CD6) 95+% |
— | |
CLA1254 |
|
946415-64-1 |
Foralumab (Anti-CD3e) 95+% |
— | |
CLA1228 |
|
158318-63-9 |
Bectumomab 95+% |
— | |
CLA1213 |
|
235428-87-2 |
Taplitumomab paptox 95+% |
— | |